Target intelligence / Profile preview

Innate immune pattern-recognition receptors (PRRs) (PRRs)

Target
PRRs
Molecular classification
Receptor, Pattern recognition receptor
01

Overview

Innate immune pattern-recognition receptors (PRRs) are a diverse class of sensors responsible for detecting pathogen-associated molecular patterns (PAMPs), including exogenous nucleic acids delivered via lipid nanoparticles (LNPs). In the context of mRNA therapeutics like those utilizing the ARP02 sequence—a specific luciferase-encoding mRNA construct used in the development of Alnylam's LNP technology—these receptors, primarily Toll-like receptors (TLR7, TLR8) and RIG-I-like receptors (RIG-I, MDA5), recognize the mRNA's structural features and LNP components. This recognition triggers signaling cascades involving adapter proteins like MyD88 and MAVS, leading to the production of Type I interferons and pro-inflammatory cytokines. While this response is beneficial for vaccine adjuvancy, it represents a significant safety and efficacy hurdle for protein replacement therapies, as it can lead to infusion-related reactions and reduced translation of the therapeutic protein. Strategies to mitigate this sensing include the use of modified nucleosides (e.g., N1-methylpseudouridine) and optimized LNP formulations to minimize the activation of these innate immune pathways.

Other names
Pattern recognition receptorsRNA sensorsToll-like receptorsRIG-I-like receptorsEndosomal RNA sensorsCytoplasmic RNA sensorsTLR7TLR8RIG-IMDA5
02

Mechanism of action

Activation of endosomal Toll-like receptors (TLR7/8) and cytoplasmic RIG-I-like receptors (RIG-I/MDA5) by mRNA-LNP complexes, leading to the induction of Type I interferons and pro-inflammatory cytokines via MyD88 and MAVS signaling pathways.

03

Biological functions

Immune responseSignal transductionCytokine productionInflammation
04

Disease associations

InflammationInfectionAutoimmunity
05

Safety considerations

Infusion-related reactionsCytokine release syndromeReduced therapeutic protein translationInjection site inflammation
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Interferon-alphaInterleukin-6CXCL10C-reactive protein

Beyond the preview

Go deeper on Innate immune pattern-recognition receptors (PRRs) (PRRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune pattern-recognition receptors (PRRs) (PRRs).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call